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Abstract
When pediatric patients are admitted to the inpatient or outpatient hospital setting they
potentially have to endure procedures that cause pain, fear, and anxiety which can have a
lifelong impact on the child’s response to future healthcare needs. The purpose of this
project was to create a comprehensive program proposal for a nitrous oxide sedation
program to minimize those perceptions towards medical procedures. The project utilized
a systematic review of literature and secondary data to address the most important
indicators for developing a comprehensive program proposal to present to the pediatric
leadership team. Multiple studies have shown nitrous oxide having an excellent safety
profile in the pediatric population while providing an almost pain and anxiety free
procedure. The program proposal will be used to improve pain and anxiety management
for pediatric patients requiring procedures such as intravenous access, venipuncture,
voiding cystourethrograms, lumbar puncture, bone marrow biopsy, port-a-cath access,
PICC line insertion, dressing changes, chest tubes, and wound care. Key stakeholders and
content experts were brought together to create the nitrous oxide program proposal which
included a new practice guideline, a comprehensive policy and procedure for nitrous
oxide administration, and an education plan. The program proposal included other key
components necessary for a safe and efficient program such as a pre-assessment to
determine if the child is a candidate, monitoring and documentation of nitrous oxide
administration, and education for the child/parent(s). The nitrous oxide program for
pediatrics was designed as a minimal sedation method to minimize procedural pain, fear,
and anxiety in children where medical procedures are a necessary part of treatment.
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Section 1: Overview of the Evidence-Based Project
Introduction and Background
Pediatrics is defined as a field of medicine that is concerned with the health of
infants, children, and adolescents: their growth and development and the conditions that
allow them to achieve full potential as adults (American Academy of Pediatrics [AAP],
n.d.). According to the United States Census Bureau’s 2011 data, there are 74 million
children who live in the United States (U.S. Census Bureau, 2014). There were 25.5
million under the age of six, 24.9 million aged six to 11 years, and 23.8 million aged 1217 years (U.S. Census Bureau, 2014). The percentage of the total population under the
age of 18 is projected to decrease from 23% to 20% between 2014 and 2060 (Colby &
Ortman, 2015).
Hospital admissions can be very stressful for children and their parents.
Hospitalizations can cause a great deal of emotional stress, especially in children, where
the anxiety from being away from their home environment can be traumatic (Macías et
al., 2015). Children will often miss their normal routines, interactions with their peers,
their families, and even their pets. Stress in children is usually caused by experiences that
are unfamiliar or unpredictable. These situations may present unclear expectations that
cause a fear of failing, or create anticipation of something unpleasant (Washington,
2009). Children often demonstrate negative reactions, including aggressive behaviors,
withdrawal from caregivers or family, becoming uncooperative, and showing difficulty
coping with and/or recovering from procedures performed in the hospital or outpatient
settings. These types of distress can interfere with the delivery of needed medical
attention (Rodriguez, Clough, Gowda, & Tucker, 2012). Barkley and Stephens (2000)
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found that when anxiety is decreased, children are able to approach medical situations
with a sense of comfort, achievement, and control. A suggested method to help alleviate
pain, anxiety, or fear associated with medical procedures in children is the use of inhaled
nitrous oxide.
Factors such as fear, anxiety, coping difficulties, and lack of social support can
further exaggerate the physical pain in children (Verghese & Hannallah, 2010). The use
of basic ethical principles can help nurses make evidence-based decisions that provide
optimal pain treatment for the pediatric patient (Bernhofer, 2011). Pediatric patients are
patients at a high risk for inadequate pain management. Pain assessments may be
complex due to the subjective nature of information received from the patient. Utilizing
ethical principles of autonomy, beneficence, nonmaleficence, and justice may help the
nurse advocate for the patient’s pain relief needs. Nitrous oxide sedation for anxiolysis is
a method providers can suggest to the patient/parent(s) to use to reduce pain, fear, and
anxiety associated with noninvasive, minimally invasive, and invasive procedures during
hospitalizations in the pediatric departments and in the outpatient pediatric
hematology/oncology clinic. Figure 1 describes the categorization of procedures.
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Procedures

Figure 1. Categorization of procedures

Nitrous oxide sedation has been proven to be a safe and effective method of
reducing pain and anxiety in patients and has been around for over 200 years. Nitrous
oxide was discovered in the late 1770s by Sir Joseph Priestley. Priestly discovered N₂O
through experiments on nitrous air which was a mixture of iron filings, sulfur, and water
(Clark & Brunick, 2015). Humphrey Davy went on to experiment with N₂O and found
the gas provided the sensation of pleasure, joy, and euphoria, and he felt like laughing
(Clark & Brunick, 2015). During Davy’s experiments, he experienced pain relief of a
toothache from the N₂O gas; it was at that point where he began to believe that the gas
could have some anesthetic properties (Clark & Brunick, 2015). Over the next few
decades, others continued to experiment with N₂O; however, the anesthetic properties of
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the gas were not pursued. It wasn’t until the 1840s that the anesthetic value of N₂O was
considered again. Dr. Horace Wells, a dentist, began using the gas for tooth extractions in
his dental office after he breathed the gas himself and had a colleague extract one of his
own teeth (Clark & Brunick, 2015; Ellis, 2015). Wells was recognized by the American
Dental Association (ADA) as the primary discoverer of anesthesia (Clark & Brunick,
2015).
Nitrous oxide has remained in continuous use longer than any other drug and has
never been replaced by something different; it continues to be used during procedural
sedation for pain and anxiety relief in patients undergoing invasive procedures, and it has
a remarkable safety record (Clark & Brunick, 2015). Nitrous oxide has been primarily
used in dentistry but has also been used in emergency medicine, podiatry, labor and
delivery, radiology, and as a sedation treatment for procedures not requiring general
anesthesia (Farrell et al., 2008). Over the years, procedural sedation and analgesia have
grown and have been further advanced by new drugs and monitoring technologies,
expanded practitioner skills, the need to shift procedural work to outpatient settings, and
widespread acceptance of the ethical guidelines to treat pain and anxiety in children
(Krauss & Green, 2006).
Problem Statement
Healthcare professionals who work with children frequently claim that “children
are not little adults” and have special physiologic and developmental needs; however, this
is often ignored when it comes to pain and sedation management in children. According
to the AAP and the American Pain Society (APS, 2001), there is much evidence that pain
and distress in hospitalized children is undermanaged. This may be particularly true for
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many “routine” nursing procedures, including venipunctures, IV starts, and bladder
catheterizations. Many such procedures are capable of producing a state of panic in
children (Herd, 2008). Distress and anxiety can actually increase the child’s perception of
pain (Rodriguez, Clough, Gowda, & Tucker, 2012). According to Zempsky (2008),
pediatric patients report IV placement as the leading cause of procedure-related pain in
the hospital. One study discussed by Kennedy, Luhmann, and Zempsky (2008) surveyed
2,188 pediatric, emergency, and infusion nurses and found that children were physically
restrained during IV insertion 74% of the time. Although topical anesthetics such as
lidocaine 2.5%/prilocaine 2.5% (EMLA) and intervention by the child life specialists are
valuable tools in this practice area, they are not always enough to gain the cooperation of
a frightened child (Ekbom, Jakobsson, & Marcus, 2005).
Nitrous oxide is a clear, odorless gas with sedative, amnestic, and mild analgesic
properties (Farrell et al., 2008). It has been used safely to provide conscious sedation
without loss of verbal contact with the child in a number of settings and for a variety of
procedures. The goal of this project was to develop an evidence-based N₂O program for
pediatric and pediatric hematology/oncology patients for inpatient and outpatient
procedures. The proposed plan is to expand the pediatric sedation program with the
addition of N2O as a single sedative agent for anxiolysis/analgesia use in the sedation
program. The administration of minimal, moderate, and deep sedation is an integral part
of pediatric hematology/oncology practice. Procedural sedation is the technique of
administering sedatives or dissociative agents with or without analgesics to put the
patient in a state where they are able to tolerate painful or unpleasant procedures while
continuing to maintain cardiorespiratory function (Mace et al., 2008).
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Nitrous oxide is an analgesic that is administered for the pediatric population to
reduce fear, anxiety, and pain response during minor invasive procedures. Nitrous oxide
administration would be a very beneficial addition to the sedation program for patients in
a pediatric setting. A majority of the children in the pediatric department are oncology
patients. Children who are diagnosed with cancer go through procedures such as lumbar
punctures, bone marrow biopsy and aspirations, placement of a central line at the
beginning of treatment and removing it at the end of treatment, dressing changes, port
access for chemotherapy and other medications, and/or IV starts during the course of
their treatment. Nitrous oxide administration provides for an almost pain and anxiety-free
procedure, requires neither an intravenous line nor postprocedure monitoring, and
minimizes any unpleasant memories the child may have (Burnweit et al., 2004).
Context
The environment selected for the nitrous oxide program proposal is the HSHS St.
Vincent Children’s Hospital which is located within HSHS St. Vincent Hospital. The
population of patients for the DNP Project will be pediatric patients undergoing painful
and anxiety provoking procedures, specifically in the inpatient pediatric department, the
pediatric intensive care unit, and the outpatient pediatric hematology/oncology clinic.
Children admitted to HSHS St. Vincent Children’s Hospital are cared for in one of two
pediatric locations within the 24-bed Children’s Hospital inpatient units, not including the
neonatal intensive care unit (NICU), depending on the severity of illness or injury. The
pediatric intermediate care unit (PIMCU) cares for general admissions and those patients
requiring closer observation. The pediatric intensive care unit (PICU) is reserved for
children with very severe or life-threatening illnesses where care is provided by pediatric

7

intensivists. The pediatric department and the PICU are located on the same floor,
making the transition from one unit to another easier for both patients and their families.
HSHS St. Vincent Children’s Hospital also includes an outpatient pediatric
hematology/oncology clinic that provides care to children who have cancer or blood
disorders. The clinic is located in a different area of the host hospital; however it is an
easy transition for children who are admitted for chemotherapy treatments, illness or
complications due to chemotherapy, and children needing treatment for bleeding
disorders. The HSHS St. Vincent Children’s Hospital is also affiliated with Prevea Health
Care where pediatric patients can be seen by their regular pediatrician for well-child
checks or referred to other providers.
The total inpatient days for pediatrics, PICU, and NICU during the 2015 fiscal
year was 10,371. This excludes the routine newborn population, since that population is
part of the women’s center. The number of pediatric ambulatory/short stay visits for the
2015 fiscal year was 1,075. There were 768 patients from the pediatric
hematology/oncology clinic during the fiscal year; however this number does not include
nonprovider visits. The nonprovider visits are nurse-only visits which include routine lab
checks, blood or platelet transfusions, intravenous immunoglobulin (IVIG) infusions, or
port-a-cath needle changes or flushes. The pediatric gastrointestinal clinic saw 570
patients (this is partial year data). The pediatric subspecialty clinics saw 4,369 patients
during the fiscal year and the Prevea Health pediatric primary clinics saw a total of
50,096 patients in the 2015 fiscal year.
The HSHS St. Vincent Children’s Hospital also has a pediatric procedural
sedation program. The program has made it easier and safer for pediatric patients
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undergoing both inpatient and outpatient procedures such as MRIs and CT scans, lumbar
punctures, and bone marrow biopsies and aspirations. Children requiring such procedures
usually are admitted in the morning, undergo the procedure, and are discharged the same
day. A pediatric intensivist and a PICU nurse attend to the patient throughout the
procedure, and the child is monitored until full recovery, usually in the PIMCU. The
same process occurs in the pediatric hematology/oncology clinic. The nurses in the
pediatric hematology/oncology clinic are trained to monitor patients receiving moderate
sedation as well as recover patients receiving moderate or deep sedation.
Over the last two years (11/1/2013-12/1/15) the pediatric procedural sedation
team has performed 833 cases. A majority of the sedation cases were done for children
who had cardiovascular disorders, developmental delays, infections, leukemia, seizure
disorders, hematology/oncology disorders, and neurological disorders. The top primary
problems were leukemia (217 cases), seizure disorders (117 cases), hematology/oncology
disorders other than leukemia (129 cases), and neurological disorders (213 cases). The
pediatric intensivists performed 725 cases and 106 cases were performed by pediatric
subspecialists (e.g., RN staff in the pediatric hematology/oncology clinic). The
procedures performed included bone marrow biopsies (43), Botox injections (7),
bronchoscopies (5), cardiac echocardiograms(19), CT scans (28), EEGs (68), EMGs (8),
joint injections (6), lumbar punctures for diagnostic or therapeutic reasons (48), lumbar
punctures for chemotherapy administration (196), MRIs (366), PICC line placement (20),
renal or bone scans (19), voiding cystourethrograms (14), radiology tests (25), and other
painful procedures not specified (69). The medications used for the procedures include
the intravenous medications midazolam (143 instances), propofol (699 instances),
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fentanyl (194 instances), morphine (110 instances), and lidocaine as well as 471 instances
of the topical anesthetic 2.5% lidocaine/2.5% prilocaine (EMLA). Many of the
procedures used either deep sedation or moderate sedation depending on the child’s
developmental age, anxiety towards the procedure, or parental request. The pediatric
sedation program does not have a minimal sedation method. The above procedures can be
performed utilizing N₂O (minimal sedation) because they are relatively short procedures.
Nitrous oxide can be used effectively for short procedures and has a shorter recovery time
than both moderate and deep sedation methods.
There were minimal side effects or complications seen with the sedation cases,
which involved airway obstruction (18 cases), apnea >15 seconds (2 cases), coughing (14
cases), desaturation/hypoxia (15 cases), IV related complications (3 cases), requirement
of emergent airway intervention (3 cases), snoring/partial obstruction (25 cases), stridor
(3 cases), and unexpected change in heart rate or blood pressure >30% (2 cases). There
were 769 cases without any side effects or complications.
HSHS St. Vincent Hospital is an acute care hospital within the Hospital Sisters
Health System, which is a multi-institutional health care system comprised of 14
hospitals and is the host hospital for the HSHS St. Vincent Children’s Hospital. HSHS St.
Vincent is a 255 bed hospital including adult intensive care, cardiovascular (heart center),
emergency, gynecology, hospice/palliative care, neurology, obstetrics (women’s center),
oncology, orthopedics, pulmonary, rehabilitation/physical medicine, trauma,
urology/nephrology, palliative care, dialysis, and a stroke center (HSHS St. Vincent
Hospital, 2015).
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Purpose Statement
The purpose of developing a N₂O program for pediatrics is to provide anxiolysis
and analgesia via an inhaled N₂O delivery system for pediatric patients undergoing
painful procedures or procedures that cause anxiety or fear. Statistics show that nearly 35
million people in the United States avoid procedures because of fear and anxiety (Clark
& Brunick, 2011). Fear of pain can be a huge obstacle to overcome, especially in the
pediatric patient. Invasive diagnostic and minor surgical procedures on pediatric patients
outside the traditional operating room setting have increased in the last decade and as a
consequence, the need for sedation for procedures in physician offices, dental offices,
subspecialty procedure suites, imaging facilities, emergency departments, and ambulatory
surgery centers has also significantly increased (Cote & Wilson, 2008).
Nitrous oxide sedation has primarily been used in dental practices. When used for
dental procedures in children, N₂O is typically used in longer dental procedures to
provide analgesia/anxiolysis to expedite the completion of procedures that are not
comfortable for the child (American Academy of Pediatric Dentistry [AAPD] Council on
Clinical Affairs, 2013). Using N₂O for the pediatric patient may allow the patient to
tolerate an uncomfortable dental procedure by relieving anxiety, fear, discomfort, or pain
(AAPD Council on Clinical Affairs, 2013). According to Krall (2011), nitrous oxide can
be administered in procedures such as diagnostics (x-ray films, clinical exams), minor
procedures (impressions, placement of orthodontic bands, suture removal), periodontal
(probing, scaling, root planning), restorative (fillings, crown, bridge), and surgical
(periodontal, oral surgery, endodontic, implant placement).
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Project Premise.
The premise of the project included development of a comprehensive program
proposal for an alternative method for pain and anxiety management in pediatric patients
to be used to inform the interprofessional Pediatric Policy Committee. A question
addressed by the project premise was: Will administering N₂O to pediatric patients
provide a safe, effective, comparable option to moderate sedation in reducing anxiety and
assessed or reported pain scores during invasive, potentially painful procedures?.
Program Objectives
The outcomes addressed for the N₂O program are:
1. Provide a comprehensive program proposal with recommended policies and
procedures.
2. Provide patient/family education materials that would inform families of
nitrous oxide use.
3. Present the Nitrous Oxide Program Proposal Project packet to the decisionmaking body, which would include the leaders within the pediatric
departments and the pediatric intensivists.
Using N2O as an analgesic in a sedation program provides for an almost pain and
anxiety-free procedure, and it can minimize any unpleasant memories the child may have
with the procedure (Burnweit et al., 2004). Rather than a moderate or deep sedation
method, N2O can be used for many different pediatric procedures, including lumbar
punctures, bone marrow aspirations, dressing changes, IV starts, port-a-cath access, or
wound care and it has been established world-wide as an analgesic method for painful
procedures (Kanagasundaram, Lane, Cavalletto, Kenally, & Cooper, 2001). The length of
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stay would be reduced for patients and their families because the recovery from N2O is
about 5 minutes versus 1 hour or longer for moderate or deep sedation (Clark & Brunick,
2015). Nitrous oxide administration has been proven to be safe minimal sedation option
as compared to moderate or deep sedation. Treatment with N₂O is a well-established
method for pain alleviation in children (Burton, Auble, & Fuchs, 1998; Cleary et al.,
2002; Annequin et al., 2000; Krause & Green, 2006) and has been used with good results,
in particular in children who fear the dentist (AAPD, 2013). Nitrous oxide has an
excellent safety record, has a relative ease of use, and has minimal effect on a patient’s
physiological function, making it a very versatile and safe sedative agent (Krall, 2011).
New policies and procedures, administration guidelines, documentation and
monitoring tools, fasting guidelines, patient and family education information packets for
staff, plan for staff training, and preprocedure, during procedure, and postprocedure
pain/anxiety assessment tools were incorporated into a comprehensive protocol proposal
for an evidence-based N₂O program for the HSHS St. Vincent Children’s Hospital. New
practice strategies created from this project could be placed into the pediatric
department’s strategic plan for the future, and budgets could be planned to maintain
equipment, training, and gas needed for nitrous administration.
The DNP project for developing a proposal package for the N₂O program will
reflect objectives from the Essentials of Doctoral Education for Advanced Nursing
Practice from the American Association of Colleges for Nursing (AACN): (a)
underpinnings for practice, (b) organizational and systems leadership for quality
improvement and systems thinking, (c) scholarship and analytical methods for evidence-
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based practice (EBP), (d) information systems and technology, (e) policy for advocacy,
(f) and inter-professional collaboration (AACN, 2006).
Significance to Practice
Sedation for children is very different from sedation of adults due to physiology
and age-related developmental factors. When sedation is administered in the pediatric
patient, it is usually done to control behavior to safely complete the procedure. A child’s
ability to control his or her behavior and cooperate for a procedure depends both on
chronologic and developmental age (AAPD, 2013). Children younger than six years and
those with developmental delay may require a deep level of sedation to control their
behavior for the procedure (AAPD, 2013).
An alternative sedation method is the administration of inhaled N₂O. Nitrous
oxide has rapid onset (30–60 seconds), maximum effect after about 5 minutes, and rapid
recovery upon discontinuation (Krauss & Green, 2006). Children who have received
minimal sedation (N₂O) may not require more than observation and intermittent
assessment of their level of sedation during administration (AAPD, 2008). The pediatric
patient is able to maintain verbal communication throughout the procedure when N₂O is
used along with the balance of oxygen and without any other sedatives, narcotics, or
other depressant drugs before or along with the N₂O gas (AAPD, 2008). Nitrous oxide
administration may be useful in a pediatric oncology setting for sedation in children
undergoing basic procedures such as a lumbar puncture, bone marrow biopsy and
aspiration, placing a port-a-cath at the beginning of treatment and removing it at the end
of treatment, dressing changes, peripheral lab draws, or IV starts if needed. Using nitrous
oxide has been shown to have a significant reduction in pain, allow for a shorter recovery
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time, and helps children experience less anxiety or distress during the procedures (Alai,
2014). Nitrous oxide use in these situations may create a less traumatic experience for the
pediatric patient as well as their families.
Nitrous oxide delivery is not intended to replace any of the current sedation
methods being used. It would be used to expand the pediatric sedation program by using
nitrous oxide as an analgesic/anxiolytic. The administration of minimal, moderate, and
deep sedation is an integral part of pediatric hematology/oncology practice, as well as
general pediatrics. Procedural sedation is the technique of administering sedatives or
dissociative agents with or without analgesics to put patients in a state where they are
able to tolerate painful or unpleasant procedures while continuing to maintain
cardiorespiratory function (Mace et al., 2008). Creation of a nitrous oxide program can
increase the child and family’s access to the sedative/analgesic agent (Farrell et al.,
2008).
Implications for Social Change
Pain management is an essential nursing and physician responsibility. Physicians
and nurses are very important aspects of patient and family experience. Pediatric patients
need to have positive experiences with receiving medical care, as these experiences may
influence their future feelings about their care and seeking treatment. Adequate pain
management reduces child and parent anxiety and increases compliance and cooperation
(Zempsky & Shechter, 2003). Assessment, management, and reassessment of pain are
part of the Joint Commission standards for pain. Healthcare providers and nursing staff
need to address the patient’s pain level and if the patient is experiencing pain, appropriate
care should be made available (Joint Commission, 2015). Providers and nurses
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understand that some medical procedures can cause pain and distress. They are able to
assess the pediatric patient’s level pain and anxiety and take action to prevent it, while
keeping the patient comfortable. It is their role to minimize pain using pharmacologic and
nonpharmacologic methods to alleviate pain and anxiety related to medical procedures.
The N₂O program may provide a less traumatic experience for painful and anxiety
provoking procedures in pediatric patients and provide an additional option for use in the
pediatric sedation program. Adding the N₂O as a new modality to the pediatric sedation
program offers a safe method of sedation that provides pain control and anxiety relief
quickly (Clark & Brunick, 2015). It can be easily reversed if needed by turning off the
N₂O and delivering 100% oxygen for 3-5 minutes (Clark & Brunick, 2015).
Definition of Terms
The terms pertinent to this study are described below.
Nitrous oxide/oxygen analgesia: Nitrous oxide/oxygen analgesia (also known as
laughing gas) is an inhalational anesthetic in the form of a colorless and tasteless gas
containing a mixture of nitrous oxide and oxygen. Nitrous oxide, while practically an
odorless gas, has a faint, sweet aroma and has analgesic, amnesic, and anxiolytic
properties (AAPD, 2013; Farrell et al., 2008).
Levels of Sedation
Minimal sedation: A drug-induced state during which patients respond normally
to verbal commands. Although cognitive function and coordination might be impaired,
ventilatory and cardiovascular functions remain unaffected (American Society of
Anesthesiologists, 2014).
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Moderate sedation: A drug-induced depression of consciousness during which
patients respond purposefully to verbal commands, either alone or accompanied by light
tactile stimulation. Reflex withdrawal from a painful stimulus is not considered a
purposeful response. No interventions are required to maintain a patent airway, and
spontaneous ventilation is adequate. Cardiovascular function is usually maintained
(American Society of Anesthesiologists, 2014).
Deep sedation: A drug-induced depression of consciousness during which
patients cannot be easily aroused but respond purposefully following repeated or painful
stimulation. The ability to independently maintain ventilatory function could be impaired.
Patients might require assistance in maintaining a patent airway and spontaneous
ventilation might be inadequate. Cardiovascular function is usually maintained
(American Society of Anesthesiologists, 2014).
Procedural sedation: A technique of administering sedatives or dissociative
agents with or without analgesics to induce a state that allows patients to tolerate
unpleasant procedures while maintaining cardiorespiratory function (Adams & Dervay,
2012).
Additional Definitions
Anxiolytic: A drug that relieves anxiety.
Analgesia: A drug that relieves pain.
Anesthetic: A drug that causes anesthesia.
Amnesia: Loss of memory.
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Pain: An unpleasant sensory and emotional experience associated with actual or
potential tissue damage, or described in terms of such damage (International Association
for the Study of Pain, 2015).
Anxiety: An emotion characterized by feelings of tension, worried thoughts and
physical changes (American Psychological Association, 2015).
Fear: An unpleasant emotion caused by being aware of danger (Merriam-Webster
Dictionary, n.d).
Assumptions and Limitations
Assumptions of the project are that the literature review and secondary data
provided the necessary information to address the most important indicators for
developing a N₂O program proposal in the pediatric department and the pediatric
hematology oncology clinic, since primary data cannot be obtained from the pediatric
population.
I developed a comprehensive program proposal for consideration by the pediatric
sedation team and department leaders. An assumption is that the N₂O program will be
further developed based on the protocol package presented and that eventually the N₂O
program will be implemented, though that may take several months beyond my program
completion to work on a pilot of the program with patient contact; therefore, I will not
monitor subsequent program elements. A potential limitation of the proposed program
protocol may be that the supporting documents can take time to be accepted by the
pediatric sedation team and department leaders. Another possible limitation is that it may
take longer than expected to complete and/or revise the supporting documents for
consideration by the pediatric sedation team and the department leaders.

18

Summary
This project focused on developing a comprehensive program proposal for a
nitrous oxide program for consideration by HSHS St. Vincent Children’s Hospital’s
decision making committee to expand the pediatric sedation program to include the use
of N₂O. Nitrous Oxide sedation can be administered for the pediatric population to
reduce fear, anxiety, and pain response during minor invasive procedures. Nitrous oxide
in varying concentrations has been successfully used for many years to provide analgesia
for a variety of painful procedures in children and appears to be well tolerated in the
pediatric population with no major problems being reported with its use
(Kanagasundaram et al., 2001; Cravero, 2010; Cote & Wilson, 2008). Research supports
the safety and efficacy of N₂O in children to reduce fear, anxiety, and pain that are
associated with painful procedures.
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Section 2: Review of Scholarly Evidence
General Literature
Health care is constantly changing as new evidence and technologies surface that
support a change in practice. Evidence based practice increases knowledge on new or
changing health care needs. Nitrous oxide was introduced around 1771 by Sir Joseph
Priestly (Clark & Brunick, 2015). Nitrous oxide is an inorganic inhalation agent that is
colorless, odorless (or slightly sweet-smelling), nonirritating to the tissues, and
nonflammable, though it can be combustible (Becker & Rosenberg, 2008). Nitrous oxide
is used to provide pain control and anxiety relief and can be reversed very quickly after
the procedure is completed with oxygen. The popularity of nitrous oxide and nitrous
oxide/oxygen sedation has varied over the years as some practitioners prefer to use it and
others do not view it as favorably (Clark & Brunick, 2015). However, N₂O has withstood
the test of time and is an anxiolytic/analgesic gas option that has never been replaced.
Numerous studies have shown the benefits and safety of nitrous oxide/oxygen
analgesia administration for the management of pain and anxiety reduction in children
undergoing minor surgical outpatient procedures (Annequin et al., 2000; Cleary et al.,
2002; Frampton, Browne, & Lam, 2003; Burnweit et al., 2004; Clark & Brunick, 2015;
Kanagasundaram et al., 2001; Luhman, Kennedy, Porter, Miller & Jaffe, 2001).
Researchers have addressed the efficacy, technical aspects, and cost-effectiveness of N₂O
analgesia (Burnweit et al., 2004; Clark & Brunick, 2015; Kanagasundaram et al., 2001).
Nitrous oxide has some advantages as compared to other sedation modalities for many
reasons. First of all, NPO (nothing by mouth) guidelines are not required, intravenous
access is not necessary, and in most cases patients can be discharged home without an
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escort because of the rapid washout of the gas (Clark & Brunick, 2015). The benefits of
administering N₂O are the low cost and no hospitalization (Hjortholm, Jaddini,
Halaburda, & Snarski, 2013). It has a quick induction and recovery because it enters and
leaves the brain so quickly compared to the other drugs that are given with it (Weaver,
2013).
Nitrous oxide was primarily used in dentistry and it is now being brought in as a
procedural sedation option or for minor surgical procedures. These invasive diagnostic
and/or minor surgical procedures on pediatric patients occurring outside of the traditional
operating room setting have increased markedly in the last decade (AAPD, 2002). Over
the years, procedural sedation and analgesia have grown and have been further advanced
by new drugs and monitoring technology, expanded practitioner skills, the need to shift
procedural work to outpatient settings, and widespread acceptance of the ethical
guidelines to treat pain and anxiety in children (Krauss & Green, 2006).
When sedation is administered in the pediatric patient, it is usually done to control
behavior to safely complete the procedure being performed. Pediatric procedural sedation
is common with pediatric patients due to the painful and anxiety provoking procedures
that may be a part of their treatment plan. Some of the procedures include lumbar
punctures, bone marrow biopsies/aspiration, IV starts, wound care, dressing changes,
urinary catheterization, nasogastric tube placement, and placement of a central line.
Sedative-analgesic medications can enhance the comfort and acceptance of diagnostic
and therapeutic procedures in children (Hoffman, Nowakowski, Troshynski, Berens, &
Weisman, 2002). There is a wide range of short-acting sedative and analgesic
medications being used for pediatric procedural sedation which have multiple routes of
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administration. The choice of drug is based upon the type of procedure, the anticipated
degree of pain, the targeted depth of sedation, and the patient's underlying medical
condition (Hoffman et al., 2002). Some procedures are not painful (CT, MRI, radiation,
bone scans, etc.) can but create anxiety in the child or that the child will need to remain
still during the test. Adding nitrous oxide to a procedural sedation program provides
another method to help reduce pain and anxiety in children.
Specific Literature
Painful and Anxiety Provoking Procedures
Intravenous (IV) Access and Venipuncture. Statistics show that nearly 35
million people in the United States avoid procedures because of fear and anxiety (Clark
& Brunick, 2011). Fear of pain can be a major obstacle to overcome, especially in the
pediatric patient. Children who may require repeated invasive medical procedures have
anxiety and fear over needles. It can be extreme enough where they develop a needle
phobia. Fear of needles is very common in the pediatric population and could result in
poor cooperation from the child. Due to poor cooperation, children may need to be
restrained during venipuncture, resulting in negative experiences and memories for the
child and those involved (Williams, Riley, Rayner, & Richardson, 2006; Thurgate &
Heppell, 2005). An anxiety or fear response can be triggered in children when they are
exposed to or are anticipating a venipuncture which is often expressed by crying,
psychomotor agitation, freezing, or clinging to a parent or family member (Thurgate &
Heppell, 2005).
Several studies suggest treatments that can be used to alleviate anxiety, fear, and
pain related to IV access and venipuncture are N₂O and 2.5% lidocaine/2.5% prilocaine
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(EMLA) cream. EMLA cream is similarly effective in providing pain relief from
venipunctures in pediatric patients (Paut, Calméjane, Delorme, Lacroix, & Camboulives,
2001; Hee, Roy, & Ng, 2003). Even with the use of EMLA cream, school-aged children
would be aware of the needle and could react by showing anxiety due to expected pain
associated with venipuncture (Hee, Roy, & Ng, 2003). Application of EMLA cream can
cause vasoconstriction, which may result in difficulty obtaining IV access (Furuya et al.,
2009; Hee, Roy, & Ng, 2003). Nitrous oxide may be advantageous over EMLA cream in
reducing pain-related fear and anxiety. Kanagasundaram et al. (2001) and Furuya et al.
(2009) reported that 50% to 70% N₂O inhalation for three minutes was effective in
reducing venipuncture pain in children. Carbajal et al. (2008) found that nitrous oxide
was only slightly better than 2.5% lidocaine/2.5% prilocaine (EMLA) in controlling
injection pain; however, the combination of the two was significantly better than either
intervention alone with limited side effects (Abdelkefi et al., 2004). Similar studies also
showed no difference in pain reduction between nitrous oxide and EMLA cream, but a
statistically significant synergistic effect was found when combined (Abdelkefi et al.,
2004; Hee, Roy, & Ng, 2003; Paut, Calméjane, Delorme, Lacroix, & Camboulives et al.,
2001). Treatment with N₂O increases the quality of care by facilitating
venipuncture/venous cannulation without prolonging the effective time and makes it
possible to complete all procedures and examinations (Ekbom et al., 2005).
In summary, N₂O has been found to be a safe and effective conscious sedation
agent for needle sticks across a variety of settings and in a number of different cultural
groups. The quality of evidence in support of this is quite good overall. Nitrous oxide
works at least as well as EMLA, particularly for children over the age of 4 years, and
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may work better in some instances. In particular, for children with more difficult IV
access, such as obese clients, N₂O may be more beneficial than EMLA. Distress from
fear of the mask must be taken into consideration and weighed against the potential
benefit of greater pain control in younger age groups. A combination of N₂O and EMLA
has been shown to have a synergistic effect on pain control in several studies.
Voiding cystourethrograms. A voiding cystourethrogram (VCUG) is a
radiologic imaging technique that is used in diagnosing and follow-up of a variety of
childhood diseases, including urinary tract infection (UTI) in children under 1 year of
age, older children with recurrent UTI, children with ureteric dilatation, terminal
hematuria accompanied by symptoms of lower urinary tract disease, renal failure of
undetermined cause, certain voiding problems, thick-walled bladder detected with
ultrasonography, and infants with significant hydronephrosis detected via ultrasound
prenatally (Akil et al., 2005). VCUG testing is considered to be an invasive procedure,
mainly due to the uncomfortable experience of bladder catheterization (Akil et al., 2005).
Bladder catheterization for radiologic imaging can cause a great deal of psychological
distress, pain, and anxiety in children (Zier, Kvam, Kurachek, & Finkelstein, 2007; Zier,
Drake, McCormick, Clinch, & Cornfield, 2007). Several studies suggested oral
midazolam and 50% inhaled N₂O were comparable treatment methods to reduce pain and
anxiety associated with bladder catheterization for VCUGs; however, N₂O has an
excellent safety profile, a more rapid onset, shorter recovery time, and fewer side effects
than oral midazolam (Keidan et al., 2005; Zier et al., 2007; Zier et al., 2007; Farrell et al.,
2008).
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In this limited number of studies, N₂O was found to be better at relieving distress
compared with a control state (Zier et al., 2007), and to be at least as effective as oral
midazolam for VCUGs (Keidan et al., 2005). Satisfaction data was not statistically
different between N₂O and oral midazolam, but clinically significant for the individuals
previously treated with oral midazolam (Farrell et al., 2008). In two studies with a
relatively large number of combined participants, no serious adverse events were
recorded with the most common side effect being nausea and vomiting (Zier et al., 2007;
Zier et al., 2007).
Miscellaneous painful procedures. Many of the painful procedures described in
the literature were a combination of medical and nursing procedures, including insertion
of central venous catheters, facial lacerations, chest tube removal, intra-articular joint
injections, fiberoptic bronchoscopy, otologic procedures, forearm fracture reductions,
botulinum toxin A injections, lumbar punctures, bone marrow biopsies, wound care, and
a wide variety of other procedures performed in an emergency or inpatient care area
(Abdelkefi et al., 2004; Annequin et al., 2000; Bruce & Franck, 2000; Bruce, Franck, &
Howard, 2006; Cleary et al., 2002; Fishman, Botzer, Marouani, & DeRowe, 2005;
Frampton, Browne, & Lam, 2003). The use of N₂O for procedure-related pain control
was found to be superior in regards to shorter recovery times, greater clinician
satisfaction, and fewer side effects when compared to moderate, deep, or general
anesthesia (Burnweit et al., 2004; Cleary et al., 2002; Luhmann, et al., 2001).
Overwhelmingly, across studies, N₂O was found to be efficacious and safe with
high levels of patient, parent, and staff satisfaction. When physical restraint was
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measured, it was required less often in children sedated with N₂O compared with typical
rates of restraint (Abdelkefi et al., 2004; Annequin et al., 2000). Abdelkefi et al. (2004),
Bruce et al., (2006), Cleary et al. (2002), and Fishman et al., (2005) reported low pain
scores with use of N₂O. Nitrous oxide was found to be significantly more effective than
standard care in several studies (Fauroux et al., 2004; Luhmann, et al., 2001).
Administration of N₂O was found to be superior to midazolam (Luhmann et al.,
2001; Zier et al., 2007) and a combination of ketamine and midazolam (Luhmann,
Schootman, Luhman, & Kennedy, 2006). Mixing N₂O with midazolam did not confer
any additional benefit, but did increase the risk of adverse effects (Luhmann et al., 2001).
Nitrous oxide was equally as effective as morphine with a faster recovery time for chest
drain removal in a small randomized controlled pilot study (Bruce et al., 2006). A few
studies reported N₂O to be less effective in younger age groups, usually defined as two to
three years or younger (Annequin et al., 2000; Fauroux et al., 2004). Frampton et al.,
(2003) stated there were good results in younger children, but no specifics about efficacy
or safety in this age group were provided. Kanagasundaram et al., (2001) discuss that
administration of N₂O for painful procedures in children maintains low distress scores
during the painful phase and its most appropriate application is for children over the age
of 6 and for short procedures.
Adverse Events and Contraindications
Nitrous oxide/oxygen analgesia use in pediatric procedural sedation is not without
risks. The American Academy of Pediatrics (AAP) warns that greater than 50% of N₂O
may increase the chances of deep sedation (AAP & AAPD, 2008). The risk of over-
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sedation is decreased when N₂O is used at lower concentrations (below 50%) (American
Society of Anesthesiologists, 2002; Farrell et al., 2008; Frampton et al., 2003;
Kanagasundaram, et al., 2001).
Nausea and vomiting are the most common side effect of N₂O. Administration of
N₂O does not cause serious side effects (apnea and desaturation below 92%) and the
incidence of mild adverse events (diaphoresis, nausea, vomiting) are low occurring in
approximately 0.5-4% of patients (Zier et al., 2007; AAPD, 2013). A higher incidence is
noted with longer administration of N₂O, fluctuations in nitrous oxide levels, and
increased concentrations of N₂O (AAPD, 2013).
Overall, serious adverse events were extremely rare, and generally resolved upon
discontinuation of the N₂O. One rare adverse event associated with N₂O is inactivation of
vitamin B12. Nitrous oxide inactivates vitamin B12, inhibits the enzyme methionine
synthase, and increases plasma total homocysteine with prolonged exposure to N₂O and
can lead to neuropathy, spinal cord degeneration, and even death in children (Baum,
Willschke, & Marciniak, 2012; Kanagasundaram et al., 2001). Individuals with
subclinical vitamin B12 deficiency may be more prone to develop deficits after more
limited exposure to N₂O (Singer, Lazaridis, Nations, & Wolfe, 2008; Clark & Brunick,
2015). Patients with B12 deficiency can experience post-procedure effects such as
myelopathy and neuropathy (Clark & Brunick, 2015).
Inhaled N₂O provides pain relief, sedation, and alleviation of anxiety
(Kanagasundaram et al., 2001). Oversedation in one study happened in about 2.9% of
sedation episodes, occurring more frequently among children receiving 70% N₂O (Babl,
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Oakley, Seaman, Barnett, & Sharwood, 2008). The majority of patients in these studies
achieved a level of sedation consistent with conscious sedation without loss of verbal
contact with the child (Babl et al., 2008; Zier, Tarrago, & Liu, 2010). No statistically
significant differences were found in the incidence of adverse events in children receiving
< 50% N₂O and those receiving higher percentages (Babl et al., 2008; Zier et al., Liu
2010).
Nitrous oxide has an excellent safety profile; however, more children under three
years of age had a higher risk of reaching deep sedation (Babl et al., 2008), a higher rate
of adverse events in children less than one year of age (Gall et al., 2001), a higher rate of
adverse events (Gall et al., 2001), and a deeper level of sedation (Zier et al., 2010) in
children who had received additional sedation medications. Other studies did not find a
difference in the rate of adverse events among different age groups (Zier, Tarrago, & Liu,
2010). Although N₂O has demonstrated an excellent safety profile, providers must be
prepared for a deeper level of sedation than intended and potential adverse events,
particularly in the younger age groups and in children receiving concomitant medications.
Across all studies, major adverse events were quite rare. There were rare reports
of patients being more deeply sedated than intended (Burton et al., 1998), but these
episodes resolved without further intervention upon discontinuation of the N₂O. Brief
desaturations were noted in a few studies (Fauroux et al., 2004; Zier et al., 2007), but all
resolved without intervention. Common side effects included euphoria, dizziness,
headache, nausea and vomiting.
Nitrous oxide is contraindicated in children with bowel obstructions,
pneumothorax, cystic fibrosis, suspected or known pernicious anemia or vitamin B12
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deficiency, cancer therapy using bleomycin, head injuries, inability to understand
procedure or unwilling to provide consent, and intrathoracic injuries (Clark & Brunick,
2015). Nitrous oxide use should not be administered for patients with cystic fibrosis or a
pneumothorax. When N₂O is given in patients with a pneumothorax, the expansive
quality of the gas causes an increased expansion and size of the pneumothorax (Clark &
Brunick, 2015). Administration of N₂O should also be avoided in children with cystic
fibrosis. The expansive nature of the gas may cause bullae. Since nitrous oxide increases
intracranial pressure by the rapid replacement of nitrogen with N₂O in air spaces, it is
contraindicated in children with closed head injury and altered intracranial compliance
(Clark & Brunick, 2015).
Patient and Parental Response
Several studies reported a high level of staff satisfaction with N₂O (Abdelkefi et
al., 2004; Annequin et al., 2000; Luhmann et al., 2001). Annequin et al. (2000) reported
that 93% of children who were able to answer the question said they would accept N₂O if
another procedure was to be performed. Satisfaction immediately after and two hours
after the procedure was higher in the N₂O group in another study (Fauroux et al., 2004).
Zier et al. (2007) found that parents rated satisfaction with N₂O sedation higher than prior
sedations with midazolam. In a study by Williams et al., (2006), parents and children
were highly satisfied when N₂O was used for the procedure. Parents stated that the
procedure was less stressful, their child did much better with the N₂O, and that they
would highly recommend it (Williams et al., 2006). Children’s comments included how it
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made them feel sleepy, they forgot about the procedure, the procedure went very fast, and
that it had a tingly, light feeling (Williams et al., 2006).
Distraction and positive incentives are strategies that have become an important
part of the technique for nitrous oxide administration for procedural sedation. Distraction
is a great technique that can be used prior to and while administering the N₂O.
Distraction techniques are used to keep the child calm while wearing the mask which can
be a source of anxiety. Offering incentives when the child completes the procedure is also
a great method of distraction as it is something the child looks forward once they are
finished. Parent variables that may influence the success of parent distraction coaching
for the child include ethnicity, gender, previous experience, belief about their ability to
use distraction, anxiety, and parenting style (Kleiber & McCarthy, 2006). Variables may
affect a child’s response to pain during procedures are age, sex, diagnosis, ethnicity,
previous experience, temperament, anxiety, coping style, genotype, and ability to pay
attention.
There is also relationship between parents’ affective responses before and during
treatments and children’s responses to the treatment (Harper, Penner, Peterson, Albrecht,
& Taub, 2012). Penner et al. (2008) found negative associations between parents’
empathic concern and children’s pain/distress; meaning, the more empathic concern
parents experienced prior to treatments, the less pain/distress children were observed to
experience during the treatments. Children vary greatly in their response to pain. An
important factor in young children’s reaction to pain is caregiver behavior at the time of
the pain (Walsh, Symons, & McGrath, 2004). Some children are able to tolerate
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procedures or treatments without any calming or distracting interventions, but others
struggle despite any efforts made to help the child stay calm.
Education
With all new programs education is a priority. Education should contain evidencebased practices (EBP) to provide the most current information. Evidence-based practice
is using the available evidence to make decisions about the care of the patient, and it
combines information about research results, clinical expertise, patient concerns and
patient preferences (Johansson, Fogelberg-Dahm, & Wadensten, 2010). The EBP
information will be used to build on current knowledge.
Patient education. Benefits of patient education include reducing complications
of treatment, enhance patient self-confidence, assist the education of health behaviors,
promote improved function and recovery, elevating patients’ potential to follow a plan of
care, easing the understanding of their condition, and empowering patients to make their
health care decisions (Patient Education Institute, 2013). Organization wide benefits
include complying with regulatory standards, have a greater amount of informed patients,
elevate customer satisfaction, and increase efficiency with cost-effective care (Patient
Education Institute, 2013). A well informed, educated patient and/or family member are
able to actively participate in their own care, improve their outcomes, help identify errors
before they occur, and reduce the length of stay (Patient Education Institute, 2013).
Effective patient education can have a large impact on the quality of care given to
the patient and family, patient safety, and can have improved patient/family satisfaction
(Tamara-Lis, 2013). For education to be effective it needs to be provided at the literacy
level or the patient and/or the primary learners. More than one-third of all American
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adults lack sufficient health literacy to completely understand instructions given at,
during, or after discharge from the hospital or in outpatient healthcare settings (TamaraLis, 2013). Providing a N₂O fact sheet that is easily understood at any health literacy
level in combination with face-to-face education will help the patient and family member
understand the use of N₂O, the side effects, and it’s effectiveness for some painful and
anxiety provoking procedures. Offering educational material will help the patient and
family make an informed choice about the sedation method they would prefer for their
child to receive during their procedure.
Nurse and provider. Education is important because it lays the groundwork and
allows further advancement in healthcare. Healthcare is a rapidly changing environment.
Changes in practice require education to properly implement the change. Proper
education arms the nurses and providers with the knowledge, competency, and skills that
promote safe and effective high quality care (The Society for Pediatric Sedation, n.d.).
Staff training is necessary prior to administering N₂O for patient procedures. Governing
boards and licensing agencies may require specific courses and training in N₂O use
before providers can use it in their clinical practice settings (Clark & Brunick, 2015). The
certification program should include didactic education designed to address the
pharmacology, toxicity, and environmental safety of nitrous oxide as well as the
equipment used for its delivery (Farrell et al., 2008). Organizations may require three to
five monitored administrations before the practitioner can administer nitrous oxide on
their own (Farrell et al., 2008). The pediatric intensivists will be key players in providing
N₂O education for the staff. Once they complete the certification course and training,
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they will be able to provide education to the staff in the pediatric department and in the
pediatric hematology/oncology clinic. Education on how to use and set up the equipment
will be provided by the product vendor. All pediatric staff currently have pediatric
advanced life support (PALS) certification. The pediatric hematology/oncology and
PICU staff have completed competencies for administering and monitoring of conscious
sedation procedures. The PICU nurses and the pediatric hematology/oncology nurses will
be the primary staff who will monitor the patient during and after administration of N₂O.
Change Management
Change is a constant in healthcare. Change management includes planning for,
managing, and reinforcing change. Change management is the process, tools and
techniques to manage the people-side of change to achieve the required outcomes (Prosci,
2015). Change management incorporates the organizational tools that can be utilized to
help individuals make successful personal transitions resulting in the adoption and
realization of change (Prosci, 2015). Slack (2011) states, in processing change we must
identify the problem, agree there is a problem, have support and be able to implement a
process to make changes. In addition, the involvement of nurses providing effective
workforce planning, collaboration among necessary colleagues and use of previously
collected data will gain policy agreement (Institute of Medicine, 2010).
Designing, implementing, and managing successful change depends on the
quality of the management team, specifically how the team works to facilitate the change
process. The key members of the N₂O program will be the executive director, the
pediatric intensivists, pediatric and PICU department manager, the pediatric
hematology/oncology manager, and assistance of the DNP student. Change management
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requires wide range of resources including relational, operational and strategic
competencies (Yukl, 2006; as cited in Macphee & Suryaprakash, 2012). The N₂O
program will need to utilize resources from other disciplines to make the program a
success. The leaders will work closely with anesthesia, biomed, clinical engineering, and
finance during the program development.
Change management can be one of the most important and difficult leadership
responsibilities (Yukl 2006; as cited in Macphee & Suryaprakash, 2012). Leading teams
into a change process can be difficult. The change project needs involvement of key
stakeholders and buy-in from the group where the change will be implemented. Without
buy-in from the staff, there is a high likelihood the change process will fail.
Organizational readiness for change is essential for implementation of a change to be
successful. Organizational readiness can be present at the individual, group, unit,
department, or the organizational levels (Weiner, 2009).
Leaders can drive change and help an organization cope with the change (White
& Dudley-Brown, 2012). They also have the ability to influence others and drive
outcomes. A leader must have a clear understanding of where the organization is today,
the current health care climate, and the mission and vision of the organization (Elwell &
Elikofer, 2015). Healthcare leaders must understand the value and critical importance of
delivering a style of leadership that will ensure that their staff feels empowered and
supported as they work through and implement changes (Delmatoff & Lazarus, 2014).
Leaders who do not take into consideration the needs of their staff, the change may be
met with resistance or confusion. Leaders may encounter many difficulties associated
with change. If they foster an organizational culture of support, empathy, and shared
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success the staff may be more receptive to the change (Delmatoff & Lazarus, 2014). The
most important traits of a leader involved in change management includes setting goals
so the team knows what they are working towards; discuss and present desired outcomes
so the team can brainstorm ideas to gain buy-in (Elwell & Elikofer, 2015); honesty;
ability to delegate tasks; maintain open communication; have confidence and
commitment in the team and the work being done; to have a positive attitude; have
creativity and intuition; and be able to inspire the team.
Conceptual Models or Frameworks
The American Academy of Pediatrics and the American Pain Society (2001) list
the following barriers to treatment of pain in children (p. 793):
1. The myth that children do not feel pain the way adults do and that there are no
negative consequences to pain in this age group.
2. Lack of assessment and reassessment for the presence of pain.
3. Misunderstanding of how to conceptualize and quantify a subjective
experience.
4. Lack of knowledge of pain treatment.
5. The notion that addressing pain in children takes too much time and effort.
6. Fears of adverse effects of analgesic medications.
Because of these barriers, children’s pain often goes undertreated.
In response to the undertreatment of children’s pain, Huth and Moore (1998)
proposed a prescriptive theory of acute pain management in infants and children. This
middle-range theory that was developed from the Acute Pain Management Guidelines
can be well-summarized in the following propositions (Huth &Moore, 1998, p. 26):
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1. An initial assessment includes concepts of past and present pain history,
developmental level, coping, and culture. This will lead to the choice of
appropriate therapeutic interventions.
2. Therapeutic interventions include child-parent teaching, pharmacologic, and
non-pharmacologic interventions.
3. Reassessment consists of regular assessment of pain by child or parent report,
assessment of behavioral and physiological states, and assessment of side
effects. Reassessment leads to identification of inadequate pain relief,
behavioral distress, unacceptable physiological measures, and side effects, all
of which contribute to the choice of appropriate therapeutic interventions.
The end result of this model is pain reduction that is satisfactory to child, parent, and
nurse. This theory has the potential to help nurses ensure that infants and children suffer
less and avoid the consequences of unmanaged pain (Huth & Moore, 1998).
This conceptual model can be adapted to incorporate pain and anxiety reduction
in procedural sedation for children. A thorough initial assessment of previous experiences
with pain and sedation and consideration of developmental level, individual coping
strategies, and culture can lead to the selection of therapeutic interventions. In addition to
child-parent teaching, pharmacologic agents, and non-pharmacologic agents, N₂O could
be used to help provide pain and anxiety relief for procedural sedation. Regular
assessment of pain, behavior, physiologic states, and side effects helps to identify
inadequate pain and anxiety control, leading to the selection of additional therapeutic
interventions. While N₂O is quite effective, it does not work for everyone or for every
procedure, so nurses must be alert to the need for additional interventions to manage pain
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and anxiety. The end result will be pain and anxiety reduction that is satisfactory to child,
parent, and nurse.
The National Guideline Clearinghouse has developed a guideline titled,
“Sedation in Children and Young People: Sedation for Diagnostic and Therapeutic
Procedures in Children and Young People”. The guideline discusses the scope,
methodology, recommendations, provides evidence for the recommendations, the
benefits and harms of implementing the guideline, recommendations, and implementation
of the guideline. The objective of the guideline is to offer best practice advice on the care
of children and young people under the age of 19 undergoing sedation for diagnostic or
therapeutic procedures (National Institute for Health and Clinical Excellence, 2010).
Major recommendations of the guideline include (National Institute for Health and
Clinical Excellence. (2010):
•

Pre-sedation Assessment, Communication, Patient Information, and Consent.
o Suitability for sedation.
o Choosing the most suitable sedation technique.
o Enabling the child or young person and their parents or care giver to make
an informed decision, offering them verbal and written information.

•

Fasting prior to procedure.

•

Psychological preparation for the child and their parents.

•

Personnel and training for staff.

•

Clinical environment and monitoring.

•

Discharge criteria for the patient.
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Each of the elements of the National Guideline Clearinghouse will be incorporated in the
N₂O program proposal package to be presented to the Pediatric Sedation team and the
department leaders.
Summary
The literature summarized here represents a wide variety of pediatric populations
from across the world; a variety of inpatient, outpatient, and emergency settings; and a
wide variety of painful or anxiety-provoking procedures. The amount of evidence
supporting N₂O use is quite good overall, with several randomized controlled trials as
well as large-scale observational studies demonstrating safety and efficacy. While N₂O
may not be enough for extremely painful procedures and may provide less benefit
compared to risk in younger age groups, it has demonstrated a high degree of efficacy
with a wide safety profile in children. Such an agent has the potential as an intervention
to improve pain and anxiety management for procedural sedation to assure it is
satisfactory to the child, parent, and nurse.
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Section 3: Approach
Project Design/Methods
Once the program protocol package is presented to the pediatric sedation team
and department leaders, it can be finalized and certain elements such as patient/family
education materials and the policy and procedure can be branded for the HSHS St.
Vincent Children’s Hospital. After approval of the program proposal and staff education,
a pilot study can be performed by the pediatric intensivist and the nurses who monitor the
patient during administration of nitrous oxide. The proposed pilot test may be performed
on two groups: children who receive moderate sedation (morphine/versed) and children
who receive nitrous oxide as an anxiolysis/analgesia agent. The providers will assess and
select which patients will receive either the N₂O or moderate sedation option and consent
will be obtained. As part of the proposed pilot study, questionnaires will be distributed to
each patient/parent(s) to measure how the child fared with the designated method. The
child and/or parent(s) will be asked to rate their experience with the treatment they
received and note the child’s level of pain and/or distress with the procedure. The data
from the surveys will be compiled to determine if N2O administration is an effective and
safe, comparable option that can be used to reduce assessed and reported pain during the
particular procedure. The results will be shared with the staff and providers. Pilot study
and data collection will be performed by pediatric staff and providers once the nitrous
oxide program has been developed by the staff.
Population and Sampling
The population chosen for this project proposal will be pediatric patients admitted
to the hospital in the pediatric and PICU departments and pediatric patients in the
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outpatient pediatric hematology/oncology clinic. Sampling will be data from the RNs,
LPNs, NPs, MDs, and child life specialists from pediatrics and pediatric
hematology/oncology.
Project Team
In addition to myself, the project team will include pediatric intensivists, the
executive director, the pediatric/PICU department manager, and the pediatric
hematology/oncology manager. This will be the core group working on developing the
program. The core team has been chosen based on their leadership roles in the
department. The project team will meet on a regular basis (at least monthly) to provide
updates on the progress of the project and/or delegated tasks. Communications can also
be done through e-mail and phone conversations. Once the proposal package is
completed, the I will present it to the project team for necessary changes and feedback.
Once approved, the departments can begin educate the staff on administration of nitrous
oxide and begin utilizing it for painful and anxiety provoking procedures.
Key stakeholders in the process include RN staff (pediatric inpatient, PICU, and
pediatric hematology/oncology clinic), anesthesia, purchasing, biomedical staff,
finance/billing, and child life specialists. The patient and parents will also be involved
once the pilot begins. The stakeholders will be brought into the team meetings when
appropriate. The comprehensive program proposal will be presented to the team at the
initial meeting. This will provide valuable feedback for the for me as I finish the program
proposal. At initial meeting all of the background information and work will be discussed
with the team and a timeline for developing the program will be created. Stakeholders
outside of the department will be notified of the program development and that they may
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be called upon to provide additional assistance. All members of the team work within the
organization with the exception of the product vendor. I will facilitate team meetings,
delegate tasks to appropriate team members, and assist with development of tools
necessary for the program.
The department has already received grant money to purchase equipment and has
planned for the program in the current year’s budget. A product quote will be provided by
the vendor. The team member from purchasing will be asked to attend a meeting to
discuss purchasing the products chosen from the vendor. The pediatric
hematology/oncology clinic was recently renovated and has nitrous oxide piped into the
procedure rooms that are ready for use.
Data Collection
I propose a pilot study when the staff begins to implement the N₂O program. The
documents created for the DNP project will be used for data collection during the pilot
study. Data collection will be from staff in the pediatric units and the pediatric
hematology/oncology clinic. This will be in the form of a needs assessment from the
RNs, LPNs, NPs, MDs, and child life specialists created in SurveyMonkey and
disseminated through e-mail that will determine educational needs. The IRB I received
from the facility will need to be reevaluated to conduct the needs assessment. Data will
also include the number of moderate sedations using morphine and versed for painful
procedures. A questionnaire will be developed for the patient/parent(s) for data collection
before, during, and after the procedure performed to gather information on how they felt
the N₂O made the procedure tolerable; the effectiveness of N₂O; if they would
recommend it for various types of procedures; and if they would use it for future
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procedures. Staff involved in the procedure using N₂O will also complete a questionnaire
to include the type of procedure, length of time gas is administered, any complications
identified, ease of use, patient tolerance, patient pain levels before, during, and after the
procedure, and if N₂O is recommended for future use.
The only archival data that may be included is a sedation report that identifies the
number of sedations performed in pediatrics and in the pediatric hematology/oncology
clinic. This report can be run by the pediatric intensivist and provided to me. The report
contains no names and only lists the sedation method used and the procedure performed.
Another source of data collection would be in the form of reported pain and anxiety. Pain
assessment is a requirement of the Joint Commission. There are a variety of tools that can
be used to assess pain and anxiety that are appropriate for the child’s developmental age.
A variety of tools can also be utilized for measurement of pain. Most are behavioral pain
scales, acknowledged by some authors as a limitation that makes it difficult to separate
pain from anxiety (Carbajal et al., 2008). Pain and anxiety are both outcomes of interest
for this project. The reliability and validity of several of these scales such as the
Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS) and Observational Scale of
Behavioral Distress (OSBD) are well-established and are described in systematic reviews
of such behavioral pain tools (Von Baeyer & Spagrud, 2007; Crellin, Sullivan, Babl,
O’Sullivan, & Hutchinson, 2007). Often behavioral pain scales are combined with some
type of visual analog scale rated by children, parents, and/or staff/observers. These scales
include the numeric pain rating scale (Figure 2); Wong-Baker’s FACES scale, which
measures pain intensity “faces” that correspond to pain intensity (Figure 3), and the Faces
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Legs Activity Cry Consolability Scale (FLACC) scale (Figure 4). Satisfaction on the part
of the child, parent, and/or nurse was also a commonly investigated endpoint.

Figure 2. 0-10 Numeric pain rating scale

Figure 3. Wong-Baker FACES® Pain Rating Scale to assess pain in the pediatric patient.
Permission granted from Wong-Baker Faces Foundation.
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Figure 4. Faces, legs, activity, cry, consolability (FLACC) pain scale.
Merkel, S., Voepel-Lewis, T., Shayevitz, J., & Malviya, S. (1997).
Printed with permission, The Regents of the University of Michigan.
Reliability and Validity of Pain and Anxiety Assessment Tools. The 0-10
numeric rating scale is widely used to assess pain intensity in the pediatric population. It
is generally used in children over the age of 8. Patients are asked to rate their pain on a
scale from 0 to 10, where 0 represents “no pain” and 10 represents “the worst pain
possible.” Once the patient rates their pain, the nurse will ask the patient what his or her
goals and expectations are with respect to the pain rating as a measure of satisfaction with
the current pain relief method (Hartrick, Kovan, & Shapiro, 2003). The numeric pain
scale has been validated in children 6 years and older and is a clinically meaningful tool
to guide treatment (Pagé et al., 2012).
The Wong-Baker FACES scale is a popular method of pain severity assessment in
pediatric populations. Faces scales use a series of facial expressions to illustrate a
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spectrum of pain intensity (Garra, et al., 2010). The Wong-Baker FACES scale has
proven to have content validity and has the potential to be an excellent measure of
treatment in school-aged children and adolescents (Garra et al., 2010). The FACES pain
scale is the most psychometrically sound self-report measure of pain in children between
4 and 12 years of age (Stinson, Kavanagh, Yamada, Gill, & Stevens, 2006; as cited in
Noel, McCurty, Chambers, & McGrath, 2010).
The FLACC behavioral pain tool has excellent reliability and validity in assessing
pain in critically ill adults and children (Voepel-Lewis, Zanotti, Dammeyer, & Merkel,
2010). The FLACC tool may offer an advantage as it can be used across populations and
settings, and FLACC scores are comparable to scores obtained by using 0-to-10 number
rating scales (Voepel-Lewis et al., 2010).
Data Analysis
The pilot study will be performed by the pediatric and pediatric
hematology/oncology staff using the documents I created for the proposal package. Data
analysis may include the data collected from the needs assessment to help guide staff
education and determine a general knowledge base of what N₂O is and how it is used for
painful and anxiety provoking procedures. Results from the staff and patient/family
questionnaires will also be analyzed by the pediatric and pediatric hematology/oncology
leaders to identify effectiveness of N₂O use and any recommendations. No new research
will be done directly on the patients in both pediatric and the pediatric
hematology/oncology clinic for the project.
A satisfaction survey that I created will be used by the staff to determine
satisfaction from the parents and/or patient for N₂O administration for the procedure
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being performed. Satisfaction data will be recorded from the patient and parental
experience of receiving N₂O for painful procedures, fear of the procedure, and anxiety
related to the procedure. Children will be able to rate their satisfaction with the pain and
anxiety management when explained to them in a developmentally appropriate way.
Additionally, parents and the sedation nurse will also be asked to rate their satisfaction
with pain and anxiety management of the child before, during, and after the procedure.
This data will be used to provide additional information of the overall effect of the
intervention.
Project Evaluation Plan
Process evaluation for this project will include the following:
1. Documentation of IRB approval from the Walden University and HSHS St.
Vincent Children’s Hospital.
2. Development of needs assessment from the RNs, LPNs, NPs, MDs, and Child
Life Specialists to be disseminated by the pediatric and pediatric
hematology/oncology leaders.
3. Determination of scope of practice (RN delivery versus MD delivery).
4. Obtaining a quote and purchasing equipment needed to deliver nitrous oxide.
5. Development of proposed policies and procedures, documentation on the
sedation record and sedation navigator in Epic, fasting protocol, and parent
education brochure, RN and Parent procedure surveys.
6. Determine what education is required for staff and providers.
7. Documentation of and continued report to N₂O project team.
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There are many processes that can help to evaluate the outcomes to determine if
they have been met or need to be adjusted to meet the objectives. Research states that
recovery from N2O is approximately 5-10 minutes after the gas has been stopped and the
patient is ready for discharge within 30 minutes after (Clark & Brunick, 2015). Moderate
sedation requires a minimum of a one hour recovery which could take longer depending
on the patient (J. Taylor, personal communication, August 3, 2015). Once nitrous use is
implemented, length of stay can be tested and compared to that of moderate sedation.
Nitrous oxide administration may be useful in a pediatric oncology setting for
sedation in children undergoing basic procedures such as a lumbar puncture, bone
marrow biopsy and aspiration, placing a port-a-cath at the beginning of treatment and
removing it at the end of treatment, dressing changes, or IV starts if needed. Nitrous
oxide provides for an almost pain and anxiety-free procedure, requires neither an
intravenous line nor post-procedure monitoring, and minimizes any unpleasant memories
the child may have (Burnweit et al., 2004). To evaluate this outcome, a survey would be
completed by the patient and/or parent for satisfaction and if the N2O was effective in
reducing pain, anxiety, and/or fear during the procedure. Other evaluation criteria may
include the type of patient and indication for N2O use, success of treatment, and behavior
of the patient during the procedure, and any adverse effects noted (Collado et al., 2008).
The proposal package will include tools used to assist in developing new practice
guidelines would include how the physician will assess whether or not the patient is a
candidate to receive N2O as well as consent; a monitoring tool for the sedation nurse to
use during the procedure for documentation of vital signs, O₂ saturation, pain scores, and
level of consciousness every five minutes while the gas is being administered; and a
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patient/parent survey will be created to evaluate N2O use as compared to moderate
sedation using versed and morphine.
Since this is a brand new program, there are many elements that have to be
developed such as a hospital policy, assessment tools (hard copy or in electronic medical
record), guidelines, education, and staff/parent surveys. Along with implementing the use
of N2O, there will also be a need for patient and family education; therefore, if their child
is a candidate, they are able to make an educated decision regarding which therapy they
would like their child to receive. A parent education pamphlet will be developed to give
to the parents when the procedure is scheduled so they understand what N₂O is, side
effects related to the gas, how it is used, and information regarding its effectiveness and
safety.
Proposal Package Documents
The proposal package for the N₂O program will include several components such
as a proposed policy and procedure; changes to the sedation record to include nitrous
oxide delivery that will be added to the Epic sedation navigator; proposed needs
assessment for education and knowledge base of staff; RN and patient/family procedure
surveys; sample MD order set; where providers will obtain education and who will be
deemed a champion to education staff in the departments; fasting guidelines; and
patient/family education materials. These documents will be presented to the pediatric
leaders as part of the completion of the DNP project. Evidence-based research will be
used to create the program proposal to provide the most current information regarding the
safe administration of N₂O to the pediatric patients.
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Summary
It should be noted that N₂O may not be effective or necessary for every child.
Appropriate assessment should lead to the choice of effective pain management
strategies. Some children may need pharmacologic intervention beyond N₂O and topical
anesthetics to effectively manage distress. Providing a comprehensive program protocol
package will assist in planning a successful project that meets the needs of the pediatric
patient, their parents and family, and the pediatric staff and providers.
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Section 4: Findings, Discussion, Implications
Introduction
The purpose of this project was to assess the need and gather support for
development of a comprehensive program proposal for a nitrous oxide program in
pediatrics. Nitrous oxide provides analgesia and anxiolysis. Administration of N₂O for
procedures causing pain, fear, and/or anxiety allows for better cooperation from the
pediatric patient for adequate completion of the procedure. Nitrous oxide has an excellent
safety record and provides pain control and anxiety relief that is quickly and easily
reversed (Clark & Brunick, 2015). The child remains calm and maintains verbal contact
with the administering provider during the procedure.
The goal of the project was to develop a program proposal for a N₂O sedation
program for the pediatric team to use during their development and implementation of the
program. The N₂O program will be used to minimize pain and anxiety associated with
some medical procedures. Children admitted to the pediatric department as well as the
pediatric hematology/oncology clinic often go through procedures such as IV starts,
urinary catheterization, lumbar punctures, bone marrow aspirations, central line
insertions, port-a-cath access, nasogastric tube insertions, or gastrostomy tube changes.
Each of these procedures can be pain, fear, or anxiety provoking. The goal of the nitrous
oxide program is to minimize pain, fear, and anxiety associated with those procedures,
which allows for completion of the procedure.
Discussion of Project Products
The scholarly products developed for the nitrous oxide protocol included a
proposed policy and procedure; changes to the procedural sedation record and
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documentation in the Epic Sedation Narrator to include nitrous oxide; a proposed needs
assessment for education and knowledge base of staff; RN and patient/family procedure
surveys; sample MD order set; education staff plan; fasting guidelines; patient/family
education materials; and obtaining a quote for equipment. The scholarly products were
presented to the pediatric leaders for review and approval.
Concept Map.
To begin the planning phase of the project, a concept map was created (Appendix
A). Brainstorming ideas at the beginning of the project was valuable in determining what
products would be necessary to present to the pediatric leaders to aid in their
development and implementation of the nitrous oxide program in the inpatient
departments and the pediatric hematology/oncology clinic. A concept map is a tool that
shows the main idea, subconcepts, and cross-links and organizes the relationships
between concepts (Noonan, 2011). The concept map included the stakeholders, safety,
education, policy, scope of practice, finance, equipment, tools, regulatory issues, patient
population, and the physician group. Each of these subconcepts is critical to planning a
successful program.
Policy and procedure. As part of the program protocol package, a proposed
nitrous oxide policy and procedure (Appendix B) was developed using current evidencebased practice. This policy was presented to the pediatric leaders for feedback to include
revisions and approval of the policy to continue on in the process for approval by the
organization. The pediatric medical director was a key stakeholder in developing the
policy. The director’s expertise and knowledge were very valuable in creating the policy.
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Sample MD order set. The proposed physician order set included the
concentration of N₂O/O₂ to initiate the procedure, the continued concentration
throughout the procedure, the order to administer 100% O₂ for 3-5 minutes after
discontinuing N₂O upon completion of the procedure, and a discharge order. An example
of a physician order set can be found in Appendix C. The pediatric medical director has
chosen to use the sample order set as a guide to developing the orders for N₂O
administration. Another option may be to add N₂O to the existing procedural sedation
order set.
Fasting guidelines. The pediatric sedation program has defined the fasting
guidelines as nothing by mouth (NPO) for solids after midnight, clear liquids until 2
hours prior to the procedure, and then NPO. The guidelines will remain in place for
planned procedures using N₂O. For unplanned procedures such as IV starts, difficult
port-a-cath access, or lab draws, the physician may waive the fasting guidelines. The
physician will ask the patient prior to administering N₂O what they ate or drank prior to
the procedure. Typically, patients may eat a light meal no closer than 2 hours prior to the
procedure (Clark & Brunick, 2015).
Sedation record. Documentation of a procedure of nitrous oxide will include the
concentration of N₂O/O₂ administered; the start and stop times of the N₂O; vital signs
every 5 minutes during the procedure; an Aldrete score preprocedure, postprocedure and
every 15 minutes until the patient is fully recovered and back to baseline activity; ASA
level documented in the physician’s dictation note; and a Richmond Agitation and
Sedation Scale (RASS) score during the procedure. The procedural sedation record was
updated to include N₂O for documentation (Appendix D).
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Proposed needs assessment/education plan. The proposed needs assessment
may be used by the pediatric leaders during the development of the N₂O program to
assess the knowledge base of the pediatric staff members (Appendix E). The data
collected from the needs assessment may be used to guide staff education. The same
needs assessment can be used after education to assess knowledge gained through
education.
The proposed education plan is for a select group of staff to attend a didactic and
hands-on education course offered by American Family Children’s Hospital in Madison,
Wisconsin. The course provided is taught by the assistant professor of pediatrics who is
also the associate director of pediatric sedation. The group selected may include two of
the pediatric intensivists, the managers of pediatric and pediatric hematology/oncology,
child life specialists, a PICU RN, and a pediatric hematology/oncology RN. The pediatric
intensivists will then be responsible for staff education in the departments.
The equipment vender will also be sending a clinical product specialist to do
education on the Porter Sentry Sedate N₂O system. There will be six sessions over 2 days
that are approximately one hour in length. There will also be a 15 minute video to show
how to set up, use, and break down the equipment.
RN/family survey. Once the pediatric department and the pediatric
hematology/oncology clinic begin the pilot program, surveys can be used to assess the
level of pain, distress, and anxiety the patient has before, during, and after the procedure
where N₂O is administered. The survey of the RN staff will be used to determine
satisfaction of N₂O for the procedure (Appendix F). The parent survey will be used to
determine their satisfaction with N₂O (Appendix G). The data collected from the surveys
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will be used to assess the effectiveness of N₂O sedation from both the RN staff and the
parent.
Patient and family education. Education is very important in any new program.
Nitrous oxide sedation is a new concept and the patient and family will need education
prior to choosing it for their child’s procedure. Education materials developed for the
program proposal includes a N₂O fact sheet (Appendix H) and an educational brochure
(Appendix I). Information in the educational materials includes what N₂O is, how it will
help the child during the procedure, how it is given, what the risks are, what the parent
can do to help the child, and the role of the child life specialist.
Equipment quote. Grant money will be used to purchase the equipment
necessary to deliver N₂O to the pediatric patient. The quote for the equipment was
received and the department is planning to purchase the equipment in June, 2016
(Appendix J).
Implementation Plan
The products completed for the N₂O sedation program can be used by the
pediatric leadership team to develop and implement the program in the pediatric
departments. The leadership team can continue with development of the program by
seeking hospital approval of the policy and procedure and then begin scheduling
education for the pediatric intensivists as well as a select group of nursing staff. These
individuals will be key members to provide education to the staff in pediatrics/PICU and
the pediatric hematology/oncology outpatient clinic. The vendor will also be responsible
for education on the set-up and break down of equipment. Once the N₂O program has
been developed using the products created from the DNP project, the pediatric leadership
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team can begin a pilot and collect data on the procedures using N₂O sedation. Data can
be used to determine efficiency and satisfaction with N₂O use for medical procedures.
Implications
The program proposal for a N₂O sedation program in the pediatric/PICU inpatient
departments and the pediatric hematology/oncology outpatient clinic included a hospital
policy and procedure. The policy was presented to the pediatric leaders as well as the
pediatric medical director for feedback and potential approval of the policy. The pediatric
medical director was instrumental in developing the policy. The medical director has
many years of experience in developing policies and is an expert in his field of medicine.
The feedback received on the first draft of the policy helped to revise the content to create
a solid policy for administering N₂O to the pediatric patient.
This project may pave the way for the pediatric staff to utilize a minimal sedation
method that will minimize pain, fear, and anxiety associated with some medical
procedures. The short acting and rapid recovery of N₂O can satisfy the needs of patient
and family. Parents do not like to see their children in distress. Those situations causing
pain, fear, and anxiety can set a negative tone for the child’s hospitalization and
potentially cause more trauma.
Strengths
A strength of the project was the effective interprofessional collaboration. An
advantage in the development of this project group was that most of the individuals
already worked closely together with a high degree of multidisciplinary collaboration.
Adding a N₂O sedation to the pediatric sedation program was well received by the
multidisciplinary work team. Using a minimal sedation technique to minimize pain, fear,
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and anxiety associated to medical procedures is a priority in providing the very best care
to the pediatric patient. The multidisciplinary team valued and respected each member’s
input, which contributed to excellent interprofessional collaboration and enthusiasm for
this project.
Limitations
An anticipated limitation of the proposed program was involvement of the
anesthesia department. This project involved is one of the first programs to use an
inhalation agent outside of the operating room within the institution; it was believed that
this could be seen as a “turf” issue with anesthesia. Input from the anesthesia department
was needed for many aspects of the project. According to Rose (2011), sharing such
disciplinary expertise can be perceived as threatening to an individual when that
knowledge would enable other professionals to take on aspects of that individual’s own
role. Because of the deeper understanding of children and their unique pain and sedation
needs, the director of anesthesia was approached for assistance with the N₂O program.
When members of the project team explained what the goals of the project were, the
anesthesiologists were very supportive of the program. By involving the anesthesia
department in the program proposal, they we able to maintain some control of their
identity and territory within this project.
Another limitation of the project was maintaining a meeting schedule with the key
stakeholders in the project. Each of the individuals had very busy schedules and
coordinating a time that worked for all of them was very difficult and it was rare that the
team was able to sit down together to review the proposal of the program. Much of the
communication occurred via email or sporadic individual meetings rather than the whole
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group meeting. A plan for future projects would include planning regular meetings ahead
of time to ensure the multidisciplinary team can meet as a whole group rather than
individually as time permits. The meeting times would then be on the team members’
schedule for better attendance and commitment to the project.
Analysis of Self
The past 18 months of doctoral education has expanded my engagement in a
higher level of academic activities which include program planning and development.
Prior to the doctoral education, I had minimal experience in these types of leadership
activities. New knowledge about leadership responsibilities and activities necessary for
change has been instrumental in improving confidence in leadership skills. Improved
leadership skills will assist in future planning, organizing, and facilitating program
development. Learning how to appropriately plan, implement, disseminate, and evaluate
a program allows me to become more successful with future projects and job
responsibilities as a leader.
Developing a program proposal for administration of N₂O in the pediatric patient
has been a very valuable learning experience. Leading a multidisciplinary team in
successful planning of the project was not without challenges. However, the whole team
was able to come together to approve the proposal of the program. Using the products
developed in the DNP project, the team can move forward with developing the N₂O
program in the pediatric/PICU departments and the pediatric hematology/oncology clinic
to provide the pediatric patients with a sedation method to minimize pain, fear, and
anxiety. The N₂O program can eventually be rolled out to other areas within the
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organization that serve pediatric patients such as radiology, GI lab, and the emergency
department.
As a Scholar
The AACN (1999) defines scholarship as “activities that systematically advance
the teaching, research, and practice of nursing through rigorous inquiry that 1) is
significant to the profession, 2) is creative, 3) can be documented, 4) can be replicated or
elaborated, and 5) can be peer-reviewed through various methods” (para. 1). This project
provided me with the opportunity to develop skills through building an evidence-based
program proposal for a N₂O program in the pediatric/PICU departments and the pediatric
hematology/oncology clinic. Development of the policy, education plan, staff and family
education, documentation to include N₂O for sedated procedures, staff and family
surveys to present to the pediatric leaders was a valuable experience. Preparation of the
program proposal provided me with the ability to comprehend, appraise, and interpret the
literature surrounding the safety and efficacy of N₂O administration in pediatric patients.
Through gaining an understanding of the literature surrounding N₂O I was able to apply
the most current evidence-based information into creating the comprehensive program
proposal to present to the pediatric leadership team for approval.
As a Practitioner
The doctorate preparation has provided me with better understanding of the
leadership role. Leaders are effective in facilitating change. The N₂O program is a new
program that will be implemented in the pediatric practice areas. Change is not always
well received; however, this was not the case for this project. During the preparation of
the project, there has been an overwhelming positive response from the pediatric staff for
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the N₂O program. The knowledge and skills learned at the doctoral level have allowed
me to achieve the outcomes of the project, develop a program proposal, and present it to
leaders to use for development of the N₂O sedation program. Plans are in place by the
pediatric leaders to use the proposed program prepared by through DNP project to
develop and implement the N₂O program by August 2016.
As a Project Developer
The experience of developing N₂O program offered me the opportunity to
identify an evidence-based project in the pediatric department at HSHS St. Vincent
Children’s Hospital. Experiences included working together with a multidisciplinary
team to develop a program proposal of a new sedation method to minimize pain, fear, and
anxiety in pediatric patients undergoing medical procedures, developing a comprehensive
policy for administering N₂O, preparing patient, family, and staff education. Presenting
the program proposal to the pediatric leadership team has given me improved confidence
for future program development opportunities.
Summary
According to Taddio et al. (2009), pain relief is a basic human right, and reducing
procedural pain in children demands prioritization by healthcare agencies, researchers,
and parents. Safe methods to alleviate such pain are readily available and N₂O is one
more method that can be used for pediatric patients. Greater distress during such
procedures leads to more negative memories, which can have serious effects on
compliance of treatment. Patients may avoid receiving necessary healthcare due to pain,
fear, and anxiety associated with medical procedures

59

During this project, it has become clear that changing the culture to add N₂O has
been well received by the pediatric leadership team and staff in the departments.
Enthusiasm for the eventual implementation of N₂O program has spread throughout the
pediatric departments and the staff members are looking forward to using it for future
procedures. The pediatric leadership team may be utilizing the tools and resources
created from this project to develop and implement the N₂O program.
Culture change takes time, but with better education of healthcare professionals
on the importance and ethics of pediatric pain management, interventions like nitrous
oxide could become the norm. Taddio et al. (2009), discussed that suboptimal
implementation of comprehensive pain management programs can be attributed to a lack
of knowledge about pain and effective pain prevention strategies, as well as the
persistence of attitudes and beliefs about pain that impede clinical progress in this area.
Projects such as this can educate and change the attitudes of healthcare providers so that
children receive the basic human right of effective pain management.
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Section 5: Scholarly Product
Introduction
The proposal of a comprehensive N₂O program for pediatrics was presented to
the pediatric leadership team on March 21, 2016. The leaders were able to review the
proposal and provide feedback. The policy and procedure was revised and returned to the
pediatric medical director on March 28, 2016. The products of the proposal were
approved by the pediatric leadership team and may be used for the future development of
the N₂O program in pediatrics, PICU, and pediatric hematology/oncology clinic.
Problem
Pain in the pediatric patient is often undermanaged. Pain, fear, and anxiety can be
associated to some medical procedures. Examples of routine procedures that cause these
emotions include IV starts, lab draws, port-a-cath access, lumbar puncture, and urinary
catheterization. Distress and anxiety can enhance the child’s perception pf pain
(Rodriguez, et al., 2012). Nitrous oxide is used to induce minimal sedation for these
routine procedures to help alleviate pain, fear, and anxiety in the pediatric patient.
Purpose
The purpose of the DNP project was to create a comprehensive N₂O program
proposal to present to the pediatric leadership team to move forward with their
development of the N₂O sedation program. According to the executive director of
pediatrics, adding a N₂O program was something the leaders and pediatric intensivists
have talked about since 2013. The program proposal developed through the DNP project
can enable the pediatric leaders to begin developing and implementing the N₂O sedation
program.
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Goals/Outcomes
The goals and outcomes of the DNP project were met by developing a
comprehensive proposal of the N₂O program for pediatrics and presenting it to the
pediatric leadership team. Patient and family education materials were developed to
provide information on N₂O, which was also presented. The HSHS St. Vincent
Children’s Hospital is going through the planning process and has not selected a graphic
icon to represent the hospital. Once the icon is chosen, the education materials can be
submitted to the organization for approval and branding. After the proposal was
presented to the pediatric leadership team, there was positive feedback; however, some of
the components needed revisions or modifications. The requested changes were made and
presented to the team a second time at which time they approved the materials and
allowed me to proceed with portions of the proposal that the organization needed to
approve. The procedural sedation record was approved by health information
management and was loaded into Epic forms for staff to utilize. There has been a request
to add N₂O to the Epic Sedation Narrator for documentation of the administration and
concentration of N₂O used for the procedure. The policy and procedure will be moving
forward to seek approval from the anesthesia department and then approval from the
organization.
Significance to Practice
The products created for the N₂O sedation program may be used to assist in
further development and eventual implementation of the program. Nitrous oxide sedation
provides a minimal sedation option for the pediatric procedural sedation program. Nitrous
oxide provides minimal sedation and has both rapid onset and recovery while minimizing
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the child’s pain, fear, and anxiety that may be associated with some medical procedures.
Both pain and anxiety are managed with N₂O to help the child remain calm in order to
facilitate completion of the procedure. The minimal sedation technique can reduce the
need for restraining the child to complete the procedure and can minimize the number of
needle stick for IV starts, port-a-cath access, and/or lab draws.
Literature and Evidence to Support Project
A systematic literature review was conducted using the simultaneous
CINAHL/MEDLINE database with combinations of keywords including pain, anxiety,
fear, pediatric, nitrous oxide, child, developmental ages, intravenous catheterization,
urinary catheterization, sedation, and conscious sedation. Literature from the systematic
review showed N₂O sedation having an excellent safety profile and that it can be
effectively used to minimize pain, fear, and anxiety in children due to routine medical
procedures. Nitrous oxide has anxiolytic, analgesic, and amnesic properties to help
manage pain and keep the child calm during the procedure being performed.
Frameworks
Frameworks used for the DNP project include Huth and Moore’s prescriptive
theory of acute pain in children and the National Guideline Clearinghouse guideline for
sedation in children and young people. Both frameworks discuss pain control in the
pediatric patient. Minimizing pain, fear, and anxiety during hospital admissions and clinic
visits is a priority in managing care in the pediatric patient. The frameworks discussed in
the project were incorporated when developing the products for the proposal of a N₂O
sedation program. These frameworks were used to develop the proposal which will be
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used to reduce pain, fear, and anxiety for routine medical procedures and procedural
sedation.
Summary
Input received and integrated from key stakeholders contributed to the success of
this project. Their feedback was a valuable asset while creating the program proposal for
a nitrous oxide program in pediatrics. The nitrous oxide program proposal was created to
provide a minimal sedation option to add to the current pediatric sedation program.
Managing procedural pain and anxiety in the pediatric patient is a top priority. Nitrous
oxide has an excellent safety profile and will be used to minimize procedural pain, fear,
and anxiety in children where medical procedures are necessary for treatment.
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Appendix A: Concept Map for Nitrous Oxide Program
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Appendix B: Proposed Policy and Procedure for N₂O Administration

SUBJECT: Administration of Nitrous Oxide

Effective Date:
Next Revision Due:

AREA: Pediatrics, PICU, Pediatric Hematology/Oncology
Policy#/Name: Nitrous Oxide for Anxiolysis
DEPARTMENTAL
APPROVAL:
_____________________________________________________________________
RECOMMENDED
BY:
________________________________________________________________________

Nitrous oxide use to produce minimal sedation for medical procedures in
Pediatrics, PICU, and Pediatric Hematology/Oncology.
PURPOSE: To provide guidelines for pediatric patient management of all procedures
requiring the use of nitrous oxide sedation by non-anesthesia personnel.
PROCEDURE:
I.
Procedure:
A. Indications for use:
1. Nitrous oxide may be used as a minimal sedation agent for
procedures that may cause pain or anxiety, including but not
limited to:
a. Insertion of intravenous catheter/port-a-cath access
b. PICC line insertion
c. Lumbar Puncture
d. Insertion of urinary catheters
e. Nasogastric tube insertion
f. Injections
g. Painful dressing changes
h. Gastrointestinal tube changes
i. Other minor procedures (MRI, CT, Nuclear Medicine, etc.)
B. Contraindications
1. Nitrous oxide will diffuse into a closed space or fluid filled space
and expand air, causing increased pressure within the closed
space. Nitrous oxide may also slightly increase intracranial
pressure. The potential for teratogenicity and abuse exists.
a. Pneumothorax/Pneumomediastinum
b. Intestinal obstruction
POLICY:
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II.

c. Recent middle ear occlusion or tympanoplasty
d. Pulmonary bullae or severe bullous emphysema (e.g.
caution with cystic fibrosis)
e. Air embolism
f. Decompression sickness
g. Maxillofacial injuries with potential for trapped gas
h. Intraocular surgery, penetrating injury to the globe, or
increased intraocular pressure (past 10 weeks)
i. Recent myringoplasty
j. Pneumocephalus
k. Within 3 weeks following a craniotomy
l. Increased intracranial pressure
m. Pregnancy
n. Vitamin B12 deficiency
o. Impaired level of consciousness
p. History of bleomycin administration
q. Intoxication with drugs or alcohol
r. Current or recovering drug addiction
C. Qualifications of administering provider:
1. To administer nitrous oxide, providers must complete a nitrous
oxide training course. Training includes didactic component and
monitored hands-on training to include 3 supervised nitrous
oxide administrations with an experienced mentor to establish
competency.
2. The administering provider must be qualified to recover the
patient from a level of sedation beyond that intended.
D. Qualifications of monitoring RN:
1. Nitrous oxide may only be ordered and administered by a
medical provider specifically credentialed by the Medical Staff
in the administration of nitrous oxide as a minimal sedation
agent.
2. PALS certification required and established competency in
monitoring sedations
3. Pregnant staff in the first trimester must not participate in nitrous
oxide administration.
Equipment
A. Storage of equipment and Nitrous Oxide tanks must be in a designated
locked area.
B. Replacement tanks will come from the Storeroom
C. Equipment check performed prior to sedation.
1. Oxygen and nitrous oxide tubings connected to appropriate
tanks.
2. Flow appropriately set to 3-4 L/min
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III.

IV.

3. Nitrous Oxide auto-cutoff test: Start a minimal flow of nitrous
oxide; turn off oxygen flow and be sure nitrous oxide flow also
stops.
4. Confirm the absence of leaks at pressure connections.
5. Scavenging equipment intact and prepared to operate during
nitrous oxide administration
Nitrous Oxide Pre-Anesthesia Assessment:
A. Current medical history including medications and allergies
B. Past medical history to include past anesthetic history to include
problems with anesthesia or sedation
C. Focused physical exam to include:
1. VS and weight
2. Malampati Score
3. Heart
4. Lungs
5. ASA Status
D. NPO Status
1. Follow sedation NPO guidelines located in policy #100-22-001:
Procedural Sedation (Appendix 6).
2. NPO guidelines may be waived by the medical staff provider in
special circumstances.
E. Patient/Family Preparation
1. Educate patient, parent, and/or legal guardian regarding nitrous
oxide administration.
2. Use of topical anesthetic for IV starts is recommended even if
nitrous oxide is used.
3. Involve Child Life Specialists with procedure preparations to
alleviate anxiety associated with procedure and mask.
F. Obtain informed consent
G. Perform Time Out and complete Time Out Checklist:
1. Patient correctly identified for procedure using two identifiers.
2. Patient evaluated for presence of contraindications to use of
nitrous oxide
3. Confirm that orders call for no less than 30% oxygen whenever
nitrous oxide is administered.
4. Emergency equipment available at bedside as per Policy #10022-001: Procedural Sedation (Appendix 3).
Intra-procedure Monitoring
1. Documentation of nitrous oxide concentration, pulse oximetry
value, and level of sedation will be recorded at the onset of
administration, with any changes in administered nitrous oxide
concentration, and every 5 minutes thereafter on the patient
record.
2. In addition to level of sedation and nitrous oxide concentration,
the patient’s heart rate, respiratory rate, blood pressure, and
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V.

pulse oximetry will be monitored every 5 minutes until patient
returns to pre-sedation baseline, at which point VS may be
discontinued.
3. Continuous direct observation by a qualified RN is mandatory
throughout nitrous oxide administration.
Post-procedure Monitoring
1. Stop flow of nitrous oxide and administer 100% oxygen post
procedure for 5 minutes to flush nitrous oxide from the patient’s
system and to avoid risk of diffusion hypoxia.
2. Pulse oximetry levels will be recorded until recovery is
complete.
3. Monitor for nausea and vomiting
4. Adverse event such as emesis, vasovagal reaction, seizure,
anaphylaxis or anaphylactoid reaction, cardiopulmonary
impairment, or depth of sedation deeper than that intended,
during the sedation period as well as interventions required will
be documented.
5. May discharge per physician order once patient meets discharge
criteria refer to Policy #100-22-001: Procedural Sedation.
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Appendix C: Proposed Physician Orders for N₂O Administration

Inpatient

Observation

Outpatient

Diagnosis: ______________________________________
Allergies: ___________________________________
Attending Physician: ______________________________
Weight: _________________________________________
Please CHECK desired orders.
_____ 1. Complete nitrous oxide time out prior to initiation of sedation.
_____ 2. Initiate nitrous oxide at _____% (maximum 70%) x______ minutes.
_____ 3. Continue administration at _____% to _____% (maximum 70%) for duration of
procedure (maximum ______ minutes).
_____ 4. Upon discontinuation of nitrous oxide, administer 100% FiO2 x 5 minutes to
prevent
diffusion hypoxia.

Physician Signature:______________________________Date:_______________ Time:
______
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Appendix D: Procedural Sedation Record

*Property of HSHS St. Vincent Hospital
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Appendix E: Proposed Needs Assessment
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Appendix F: RN Satisfaction Survey
Patient Pain Assessment Data Collection Form during Nitrous Oxide Administration
Gender: □ Male □ Female
Diagnosis:
Procedure:

Date of Procedure: _____/_____/_____

Pain Assessment before Sedation: Patient Response
Nurse Completes FLACC (if child <3 years old)

Nurse Asks Child FACES Pain
Rating (if child ≥3)

0-10 scale (for children <6)

Nurse’s Assessment of Patient’s Pain

No Pain
0

1

Worst Pain
Possible

2

3

4

5

6

7

8

9

10

Pain Assessment during Procedure: Patient Response
Nurse Completes FLACC (if child <3 years
Nurse Asks Child FACES Pain Rating
old)
(if child ≥3)
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0-10 scale (for children <6)

Nurse’s Assessment pf Patient’s Pain

No Pain

0

After Procedure (Prior to Discharge)
Nurse Completes FLACC (if child <3 years
old)

Worst Pain
Possible

1

2 3

4 5

6 7

8

9 10

Nurse Asks Child FACES Pain Rating
(if child ≥3)

0-10 scale (for children <6)

Nurse’s Assessment pf Patient’s Pain

No Pain

Nurse’s Estimate of Ease of
Procedure

□ Easy

□ Difficult

No Issues

Patient movement or
resistance

Nurse Ask Patient

Can you tell me about your visit today?

Non-pharmacological

□ Child Life Specialist

0

1

2

3

4

5

Worst Pain
Possible
6 7 8 9 10
□ Very Difficult
Patient movement or
resistance, traumatic
procedure
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Interventions (check all that
apply)

□ Distraction (videos, music, etc.)
□ Other (Specify): ________________________________________

91

Appendix G: Parent Satisfaction Survey

Form Completed By: □ Mother □ Father □ Other Guardian, specify:__________________

Type of Procedure:_________________________________________
Please complete form to the best of your ability by circling one number for each of the questions
below.
Before Sedation
Estimate your child’s pain

No Pain

Estimate your child’s distress

No Distress

0

Worst Pain
Possible

1

0

1

2 3

4 5

6 7

8

9 10
Worst Distress
Possible

2 3

4 5

6 7

8

9 10

During Procedure
Estimate your child’s pain

No Pain

Estimate your child’s distress

No Distress

0
0

1
1

Worst Pain
Possible

2 3

4 5

6 7

8

9 10
Worst Distress
Possible

2 3

4 5

6 7

8

9 10

After Procedure (before you leave the clinic)
Estimate your child’s pain

No Pain

Estimate your child’s distress

No Distress

Your Satisfaction with the sedation
provided for this procedure

Extremely
Satisfied

Your child’s satisfaction with sedation
provided for this procedure

Extremely
Satisfied

Did your child have any problems with
the procedure? Check all that apply.

Nausea
□ Yes □ No
Vomiting
□ Yes □ No
Combative behavior
□ Yes □ No
Unstableness when leaving for home □ Yes □ No
□ Yes
□ No

0
0

Was your child able to return back to
normal activity before discharge?
How would you compare this sedation
experience to previous sedation
experiences?

0
0

1
1
1
1

Worst Pain
Possible

2 3

4 5

6 7

8

9

10

Worst Distress
Possible

2 3

4 5

6 7

8

9

10

Extremely
Dissatisfied

2 3

4 5

6 7

8

9

10

Extremely
Dissatisfied

2 3

Please Check one:
□ Better
□ Same
□ Worse

4 5

6 7

8

9

10
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Do you have any comments or anything you would like to tell us to improve your care or experience?

Thank you very much for completing this survey!
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Appendix H: Nitrous Oxide Fact Sheet

Nitrous Oxide
Key points to Remember
It helps to be near and to comfort your child during the use of nitrous oxide.
This gas is safe for use in children and there are no long term side effects.
What is nitrous oxide?
You may know this gas as happy gas or laughing gas. It is a sweet smelling, colorless gas
used to ease pain and anxiety.
How will it help my child?
Your child may be offered nitrous oxide gas while the doctor or nurse carries out the
procedure. The gas helps to ease the pain and anxiety your child may feel, but usually
does not make them fall fully asleep.
When your child starts to breathe the nitrous oxide, they will feel drowsy within a couple
of minutes. The gas will be continued until the procedure finishes and will wear off
quickly when the gas is stopped. This means your child can quickly get back to their
usual activities (playing, eating etc.).
How will it be given?
Nitrous oxide will be given by a doctor. Before it is given, your child will be assessed to
make sure this is the best option. You will be asked to make sure your child stops eating
and drinking for a certain time before they have the gas (usually at least 2 hours, but may
be longer if other sedating medicines will be used with the nitrous oxide). This helps
reduce the risk of vomiting.
Your child will be given a mask or a mouth piece attached to a machine through which
they will breathe the gas. It can be helpful to look at, and play with the mask with your
child before the procedure starts so your child is comfortable with it before it is placed on
their face.
You are welcome to stay while your child is having the gas. The best thing you can do is
to stay where your child can see you and hold their hand. The gas will be given a few
minutes before the procedure starts and will continue until it is finished. The gas may
make your child feel 'floaty', warm and tingly. Your child may or may not remember
anything about the procedure.
When the nitrous oxide is stopped, your child will then be given oxygen through a mask
to clear the gas from their lungs. After your child has had the oxygen and is awake and
alert they will be able to eat and drink normally.
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Are there any risks?
This gas is safe for use in children and there are no long term side effects from occasional
use. Young children may not like having a mask on their face. They may feel angry or
confused by the mask and gas and will need you to stay close and comfort them. The
nurse or doctor may need to hold the mask firmly over your child's face at first until the
gas starts to work and your child relaxes.
Other side effects may occur, but they are usually minor and get better quickly. Some
children feel sick or vomit during nitrous oxide sedation. The staff looking after your
child will know how to manage these problems if they occur.
What can I do to help?
Hospitals can be frightening places for children. If a child feels sick or is in pain, it can be
upsetting to have nurses and doctors they don't know look after them. It helps if parents
stay with their child to look after and comfort them during and after most procedures. If
your child asks about the procedures being done, reassure them and explain in simple
terms what is being done and why. Always tell the truth.
At times it is helpful to tell stories, talk about the family or anything else that may help to
take their mind off the procedure. Remain calm; if you get upset so will your child. The
staff is there to help you and your child. If you would like more information please ask
the nurse or doctor caring for your child.
Child Life Specialists
A Child Life Specialist is trained in helping children and families to cope effectively with
procedures while in the hospital. The CCLS will provide age appropriate teaching of
procedures using medical dolls and age appropriate language to help the child to
understand what will be happening during their stay. They will also provide distraction
using toys, bubbles, soft music, and deep breathing throughout any procedures to keep
their mind off of what the child may be going through.
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Appendix I: Proposed Parent Education Brochure
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Appendix J: N₂O Equipment Quote

QUOTATION FOR PORTER SENTRY SEDATE
Part Number

PAK SENTRY H34-AV

PAK80010
PAK 5602-DISSVAC
PAKA-3399-000

PAKSACA120

PAKPDCA130

PAKYMCA140

Suggested
Retail
Price
Demand Flow System
Porter Sentry Sedate
MXR-1 Analog –
Hospital Package
1
$9,750.00
Accessories
O2 Hose – DISS/DISS
Connect – 10ft
1
$231.00
Vacuum Quick
Connect, DISS
1
$112.00
Replacement yoke
washers
4
$2.00
Disposables
Small Adult Full
Facemask Breathing
Circuit (box of 10)
2
$465.00
Pediatric Full Facemask
Breathing Circuit (box of
10)
2
$465.00
Youth Medium Full
Facemask Breathing
Circuit (box of 10)
2
$465.00
Description

Qty

Hospital
Price

Total
Price

$8,500.00

$8,500.00

$231.00

$231.00

$112.00

$112.00

$2.00

$290.00

$580.00

$290.00

$580.00

$290.00

$580.00

Total Price Before
Discount
Total Price AFTER
discount
Savings

Comments:
Quotation Valid for 30 days
Shipping and applicable taxes will be added to all orders

Subject to Praxair’s standard terms and conditions

$8.00

$12,891.00
$10,591.00
$2,300.00
18%
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Appendix K: Institutional Review Board Approval
Walden University granted Institutional Review Board (IRB) approval of the project on
March 18, 2016. HSHS St. Vincent Hospital also granted approval of the project on April
11, 2016 (Appendix L). The IRB determined the project does not include the types of
activities that require a traditional IRB review. This Confirmation of Ethical Standards
(CES) has provided an IRB record number of 03-18-16-0302207.
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Appendix L: IRB Approval HSHS St. Vincent Hospital

